The University of Vermont Cancer Center’s new CAR T-cell therapy program will be led by James Gerson, M.D., assistant professor in the Larner College of Medicine’s Department of Medicine, who came to UVM from the University of Pennsylvania, where CAR T-cell therapy was discovered and developed. He was among the first to administer the therapy in a clinical setting.